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Abstract
Introduction Poultry is one of the most consumed meat in
the world and its related industry is always looking for
ways to improve animal welfare and productivity. It is
therefore essential to understand the metabolic response of
the chicken to new feed formulas, various supplements,
infections and treatments.
Objectives As a basis for future research investigating the
impact of diet and infections on chicken’s metabolism, we
established a high-resolution proton nuclear magnetic res-
onance (NMR)-based metabolic atlas of the healthy
chicken (Gallus gallus).
Methods Metabolic extractions were performed prior to
1H-NMR and 2D NMR spectra acquisition on twelve bio-
logical matrices: liver, kidney, spleen, plasma, egg yolk
and white, colon, caecum, faecal water, ileum, pectoral
muscle and brain of 6 chickens. Metabolic profiles were
then exhaustively characterized.
Results Nearly 80 metabolites were identified. A cross-
comparison of these matrices was performed to determine
metabolic variations between and within each section and
highlighted that only eight core metabolites were system-
atically found in every matrice.
Conclusion This work constitutes a database for future
NMR-based metabolomic investigations in relation to
avian production and health.
Keywords Chicken  Metabolome  Nuclear magnetic
resonance spectroscopy (NMR)  Metabolite
1 Introduction
The Food and Agriculture Organization of the United
Nation (FAOSTAT: http://www.fao.org/home/en/), calcu-
lated that approximately 22 billion chickens were produced
commercially worldwide in 2012, China being the main
producer with over 5 billion birds. A major production
issue in commercial systems is animal density that is
favourable for rapid spread of disease. Most chicks receive
a cocktail of vaccines at hatch or even in ovo, but remain
susceptible to typical production related endemic disease
and other food borne zoonosis such as Salmonella or
Campylobacter (Boer and Hahne´ 1990; Dufrenne et al.
2001). All infections represent a large potential economic
loss for the chicken industry and is one of the main cause of
meat contamination by food born pathogens (Tessari et al.
2009; White et al. 1997). Vaccines and antibiotics are
commonly used to tackle such infections in order to stop
spread and symptoms and minimize the associated cost.
With regard to antibiotic use, increasing antimicrobial
resistance has been observed in animal farming and has
become a major concern in recent decades, stimulating the
development of alternative treatments (McEwen and
Fedorka-Cray 2002; Casewell et al. 2003). Therefore, in
the interest of improving animal welfare and product
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quality, new more specific treatments are needed. Finally in
the same purpose, attention is brought towards improving
animal feeding. Chichen feed generally consists of a mix of
grounded grains (corn, rice, wheat) and proteins most often
from soya beans. However, the grain/protein ratio is dif-
ferent for egg laying and meat production. There are
numerous added supplements including certain amino
acids, minerals and oils. In addition feed is supplemented
with vitamins A, D3 and riboflavine and mineral salts.
Multi-‘omics’ approaches help to gain better under-
standing of host-pathogen-drug interactions (Nicholson
et al. 2004; McDermott et al. 2011). This consists in using
together genomic (study of the genome) (Klug et al. 2012),
transcriptomic (study of gene expression) (Bernot 2004),
proteomic (studying the proteome) (Blackstock and Weir
1999) and metabonomic (studying the metabolome).
Chicken genomic (Burta et al. 1995), transcriptomic
(Murphy 2009) and proteomic (Doherty et al. 2004; Mann
2007; Mann and Mann 2008) data have already been
published but, to date, none of them have reported a
detailed analysis of the chicken metabolome. Metabonomic
has been mainly developed for clinical and nutritional
(nutrimetabonomics) research (Nicholson et al. 2002;
Holmes et al. 2011; Solanky et al. 2003; Claus and Swann
2013) and allows to look at quantitative and qualitative
metabolic variations caused by genetic mutation or envi-
ronmental stress in a sample set (Nicholson and Wilson
2003). The nutrimetabonomics approach is therefore useful
to evaluate the impact of nutrition and food on the host
systemic metabolism and understand the dietary impact on
productivity in livestock farming.
This paper presents the annotated NMR metabolic pro-
files of twelve chicken biological matrices to serve as
reference for future studies. We selected four major bio-
logical matrices for the host systemic metabolism: liver,
kidney, spleen and plasma. In addition, samples from the
digestive system, including: colon, caecum, ileum and
faecal water were analysed. Three relevant to industrial
production and that could be used to evaluate or assess
product quality: egg (yolk and white) and pectoral muscle.
Finally brain cortex was also analysed.
2 Materials and methods
2.1 Animal husbandry and sample collection
Five 15–16 weeks of age NovoGen Brown commercial
laying hens (Gallus gallus) were purchased from the Ani-
mal and Plant Health Agency (APHA) in Surrey. Animal
husbandry conformed to animal Home Office licence (PPL
70/7249) and all procedures were performed in compliance
with the Animals Scientific Procedures Act, 1986. Animals
were provided with food (Chicken Layers Pellets, Dodson
& Horrell—Composition detail in Material supplement)
and water ad libitum. After 1 week of acclimatization (see
food composition in supplement), animals of 15 weeks of
age and weighing on average 1000 g (n = 6) were sacri-
ficed by cervical dislocation. Tissues were sampled asep-
tically immediately after euthanasia and snap frozen in
liquid nitrogen (-195.79 C) and then transferred at
-80 C for storage until analysis. The following tissues
were sampled: liver (right lobe), the right kidney, half
longitudinal cut of the spleen, the right lobe of the pre-
frontal cortex, the middle of the external surface of the left
pectoral muscle. Digestive tract samples were washed with
PBS before freezing and faeces were collected directly by
emptying the colon. One cm of proximal colon was sam-
pled and 2 cm of the end on the left caecum were taken,
2 cm of ileum were sampled approximately 3 cm before
the caecum. Plasma was sampled by post-mortem cardiac
puncture. Egg yolk and white (n = 6) were sampled from
randomly chosen eggs laid by older animals that had just
come into lay (18 week old) from the same cohort of birds
on the same diet and kept within the same environment.
2.2 Sample preparation
Sample biopsies were homogenised using a bead beater
(Qiagen, TissueLyser LT) at a frequency of 1/25 for
10 min for the digestive tract tissue and the muscle and
3 min for the liver, the spleen, the kidney and the cortex
using glass beads. For this step, 0.1 g of tissue were
homogenised in 1 mL of a 3:1 (v/v) MeOH/H2O solution
for polar metabolite extraction. After centrifugation 10 min
at 12 0009g, 0.9 mL of supernatant was dried in speed
vacuum for 4.5 h at 45 C and resuspended in 600 lL of
phosphate buffer (pH 7.4) 0.2 M containing 90 % of D2O
and 10 % of H2O plus 0.01 % of sodium 3-(tri-methylsi-
lyl)-propionate-2,2,3,3-d4 (TSP) for NMR reference.
Samples were then transferred into 5 mm NMR tubes for
analysis. Egg yolk and white were prepared following the
same protocol. Plasma samples were mixed at a 2:1 (v/v)
ratio with phosphate saline buffer with 90 % D2O, of
which, 500 lL were then transferred into 5 mm NMR
tubes. Faecal samples were extracted by mixing 0.1 g of
faeces in 1 mL of phosphate buffer (plus TSP) with a bead
beater for 3 min using glass beads at the frequency of 1/25.
Samples were centrifuged at 12 0009g for 10 min in a
refrigerated centrifuge and supernatants were kept at 4 C
overnight to let urea precipitate. After centrifugation for
5 min at 12,0009g, the supernatant was transferred into
5 mm NMR tubes.
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2.3 NMR spectra acquisition
For all polar tissue extracts, egg yolk and faeces, 1H-
NMR spectra were acquired on a Bruker Advance DRX
spectrometer operating at 700.19 MHz and equipped with
a CryoProbeTM from the same manufacturer. A standard
1-dimensional noesypr1D pulse sequence (noesypr1d 90
pulse length of 7.7 ls and total acquisition time 3.34 s)
with water presaturation applied during relaxation delay
(2 s) and a mixing time of 100 ms at 298 K was used.
Plasma and egg white 1H NMR spectra were acquired
using a Carr-Purcell-Meiboom-Gill (CPMG) (Meiboom
and Gill 1958) pulse sequence to limit signal contribution
from albumin and ovalbumin respectively. CPMG were
acquired with simple presaturation of the water peak and
a total spin–spin relaxation delay (2ns) of 120 ms was
used with the following sequence (90-ts-180-ts-FID).
For each sample 256 scans (16 dummy scans) were
recorded into 64 K data points over a spectral width of
12019 Hz as for noesypr1D. 1H–1H COSY and 1H–13C
HSQC were obtained for each biological matrix on one
representative sample for metabolite identification
purposes.
2.4 Data processing and analysis
Prior to Fourier transformation, an exponential window
with line broadening of 0.3 Hz was applied to each 1D
NMR spectrum. All spectra were phased manually and
baseline corrected on MestReNova software (2013
Mestrelab Research S.L.). Spectral calibration was per-
formed using TSP (d 0.00) for all tissues and yolk
samples, lactate (d 1.33) for plasma and the H1 proton of
a-glucose (d 5.23) for egg white spectra. One represen-
tative spectrum was selected from each biological matrix
for illustration purpose and peak assignments. Each peak
was associated to a metabolite in accordance to available
database such as HMDB or previously published papers.
If a molecule presented a signature with several peaks,
the presence of all the peaks for this same compound was
assessed prior to validation by 2D NMR experiment such
as COSY and HSQC. For these spectra signal suppres-
sion was done at d 4.84 during FID processing using a
MestReNova function (with the convolution option) to
attenuate water resonance.
Signal assignment and metabolite identification was
done using an in house standard database, published liter-
ature (Merrifield et al. 2011; Claus et al. 2008; Nicholson
et al. 1995) and online public databases: the human
metabolome data base (HMDB, http://www.hmdb.ca) and
the magnetic resonance data bank (BMRB, http://www.
bmrb.wisc.edu).
2.5 Statistical analysis
For statistical analysis, spectra were imported into MatLab
(version R2013b, The MathsWorks inc.) and residual sig-
nal water region was removed (d 4.70–5.10) before nor-
malisation (to account for variations in sample size and
distribution) using a median-base probabilistic quotient
method (Dieterle et al. 2006). Principal component analysis
(PCA) was performed using algorithms provided by the
Korrigan toolbox (Korrigan Sciences Ltd) in order to
evaluate dominant sources of variation between biological
matrices. Venn diagrams were also created using online
Venny software (Venny 2.1 http://bioinfogp.cnb.csic.es/
tools/venny/).
3 Results and discussion
Systemic Metabolic characterisation of several mammals,
including rodents (Claus et al. 2008; Griffin et al. 2000;
Martin et al. 2007; Martin et al. 2009a, b), pig (Merrifield
et al. 2011), humans (Ndagijimana et al. 2009; Holmes
et al. 1997; Nicholson et al. 1995) and horse (Escalona
et al. 2014) is available but, to date, no overview of any
bird metabolic phenotype has been published despite their
industrial significance and worldwide source of protein.
This work gives a summary of the metabolic composition
of twelve biological matrices detectable by NMR spec-
troscopy in order to be used for future NMR-based
metabonomics research.
Representative 1H-NMR spectra of the twelve biological
matrices investigated in this study are presented in Figs. 1,
2, 3 and 4 to offer an overview of the chicken metabolome.
Organs and biofluids related to: the general metabolism
(liver, kidney, plasma and spleen Fig. 1), product destined
to consumption (egg yolk and white and muscle Fig. 2), the
frontal cortex (Fig. 2) and the lower digestive tract (colon,
caecum ileum and faeces Fig. 3). The numerical key for
annotation is presented in Table 1 and complementary
information provided by 2D spectroscopy for peak
assignment is given in Supplementary material 1 and 2.
3.1 Matrix characterization
The hepatic metabolic profile (Fig. 1a) was characterised
by high levels of betaine, lactate and glucose. This was the
only biological matrix where it was possible to detect
glutathione (in its oxidised form since the total pool of
glutathione becomes oxidised during tissue extraction), in
very small quantities, in contrast to what is commonly
found in mammalian hepatic metabolic profiles (Martin
et al. 2007; Waters et al. 2002; Duarte et al. 2005; Claus
et al. 2008).
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Fig. 1 Partially assigned 700 MHz 1D NMR spectra of chicken liver, kidney, spleen and plasma. Numerical key described in Table 1
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Fig. 2 Partially assigned 700 MHz 1D NMR spectra of chicken muscle, egg white and yolk and cortex. Numerical key described in Table 1. In
the figure, write egg white and egg yolk
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Fig. 3 Partially assigned 700 MHz 1D NMR spectra of chicken colon, caecum, ileum and faeces. The Numerical key is described in Table 1
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Similarly, kidney metabolic profiles (Fig. 1b) were rich
in lactate, which is consistent with the important role of the
kidney in energy metabolism. In addition, betaine and
creatine were found in very high concentrations. Betaine is
an important osmolyte in the kidney and its concentration
generally increases in case of water privation such as
diarrhoea resulting from infection. In birds the most
important kidney osmolytes are myo-inositol, betaine,
glycerophosphorylcholine, and taurine(Lien et al. 1993)
that were all detected using 1H-NMR.
The metabolic profile of the spleen was characterized by
high levels of betaine, myo-inositol and phosphocholine
(Fig. 1c). This was one of the few matrices that did not
possess any unique metabolic feature, as all the metabolites
detectable by NMR spectrometry were shared with liver,
kidney and plasma. This similarity may be explained by the
high vascularization of this tissue. In particular, it shared
with plasma high lactate and betaine levels. Unique to
plasma metabolic fingerprints were large resonances from
lipoproteins, mainly HDL and VLDL (Fig. 1d). It was also
possible to see high lactate, glucose and betaine levels. Its
metabolic profile was similar to liver, kidney and spleen,
but it was the only matrix where it was possible to identify
malate, derived from the metabolism of the citric acid
cycle.
The pectoral muscle presented the most distinctive
metabolic features in respect to the other tissue type sam-
ples, with only twenty-three identifiable metabolites
(Fig. 2a). Three metabolites were in noticeably high con-
centration: anserine, creatine and lactate. We only detected
AMP in muscle. Due to its pKa close to 7 anserine is a very
good buffer that maintain muscle pH neutrality (Boldyrev
et al. 2013). The ability of anserine to maintain a certain
pH in the muscle is known to increase the rate of glycolysis
(Davey et al. 1960). It is also a well-known antioxidant
(Kohen et al. 1988), playing an important role during
muscle contraction.
The metabolic profile of egg white had high glucose
content and presented only twenty-three
detectable metabolites (Fig. 2b). This was not surprising
knowing that egg white is relatively poor in micronutrient
and is mainly constituted of water (88 %), protein (10 %)
and less that 1 % of carbohydrates (Reserves 2007). Egg
nutritive values for embryo development are mainly
attributed to these proteins (Reserves 2007). It was also the
only matrix where we could detect glucose derived mole-
cules, such as uridine diphosphate glucose (UDPG)
involved in embryo retina development (Dreyfus et al.
1975) and UDP-N-acetyl glucosamine (UDP-GlcNAC) as
previously described by Donovan et al. (Donovan et al.
1967) that can be associated with muscle expansion (Ull-
rich et al. 1981). UDPG is involved in polysaccharide
synthesis and UDP-GlcNAC is related to glycosamino-
glycan, proteoglycan and glycolipid anabolism but nothing
specific to its role in eggs could be found in the published
literature.
In contrast, yolk polar phase metabolic profile featured
high levels of amino acids and carbohydrates such as
glucose and galactose (Fig. 2c). All amino acids essential
for protein synthesis but cysteine (that can be generated
from methionine or serine) were detectable in the yolk as
well as residual lipids that constitute 66 % of yolk dry
matter (Reserves 2007). No particularly distinctive
metabolites were observed in the yolk.
The metabolic profile of the cortex presented a high
content in myo-inositol, creatine, glutamate, taurine and
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in Supplementary material 3, the numbers in brackets indicate the
number of metabolites shared in the specified zone (between two and
four matrixes), details of the metabolites are displayed in Supple-
mentary material 3
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Table 1 1H assignment for identified metabolites and tissue/biofluid. Legend: L, liver; K, kidney; S, spleen; B, cortex; M, pectoral muscle; Ce,
caecum; Co, colon; I, ileum; F, faecal water; P, plasma; W, egg white; Y, egg yolk
Metabolite Assignement Matrix
1 2-Hydroxybutyrate CH3 0.90 t, CH2 1.70 m, CH 4.0 dd F
2 3-Hydroxybutyrate CH3 1,19 d, 1/2CH2 2.30 dd, 1/2CH2 2.39 dd, CH 4.14 m L
3 3-Hydroxyisobutyrate CH3 1.05 d, CH 2.48 m, 1/2CH2 3.53 dd, 1/2CH2 3.70 dd F
4 3-Hydroxyphenylacetate CH2COOH 3.47 s, C4H 6.78 m, C6H 6.80 m, C2H 6.85 m,
C3H 7.24 t
Co
5 4-Aminobutyrate bCH2 1.88 m, aCH2 2.29 t, cCH2 3.01 t B
6 Acetate CH3 1.92 s L, K, S, B, M, Ce, Co, I,F, P, W
7 Alanine bCH3 1.46 d, aCH 3.78 q L, K, S, B, M, Ce, Co, I,F, P, Y, W
8 b-Alanine CH2COOH 2.56 t, N–CH2 3.19 t L, K, S, M, Ce, I, P
9 AMP P–CH2 4.01 m, C1H 4.36 m, C2H 4.50 q, C3H 4.79 t, C4H
6.12 d, C8H 8.25 s, C5H 8.58 s
M
10 Anserine bCH2 2.68 m, 1/2dCH2 3.03 dd, 1/2dCH2 3.21 dd, aCH2
3.22 m, CH3 3.76 s, cCH2 4.48 m, CH 7.07 s, N–CH 8.20 s
M
11 Arginine cCH2 1.66 m, bCH2 1.91 m, dCH2 3.27 t, aCH 3.77 t L, S, P, Y, W
12 Ascorbate CH2 3.73 ddd, CH 4.01 d, C5 4.51 d S, B, P
13 Asparagine 1/2bCH2 2.86 dd, 1/2bCH2 2.96 dd, aCH 4.00 dd L, S, B, Ce, I, Y
14 Aspartate 1/2bCH2 2.68 dd, 1/2bCH2 2.82 dd, aCH 3.91 dd L, S, Ce, Co, I, F, P, Y
15 Betaine N–(CH3)3 3.37 s, CH2 3.93 s L, K, S, B, M, Ce, Co, I, F, P, Y
16 Butyrate CH3 0.88 t, bCH2 1.55 m, aCH2 2.15 t Ce, Co, I, F
17 Carnitine aCH2 2.43 m, N–(CH3)3 3.21 s, cCH2 3.42 m, bCH 4.56 m B
18 Carnosine bCH2 2.67 m, 1/2dCH2 3.03 dd, 1/2dCH2 3.16 dd, aCH2
3.22 m, cCH2 4.46 m, CH 7.08 s, N–CH s
B, M
19 Choline N–(CH3)3 3.22 s, bCH2 3.53 dd, aCH2 4.06 t L, K, S, B, Ce, Co, I, F, P, Y, W
20 Citrate 1/2cCH2 2.55 d, 1/2cCH2 2.70 d K, B, I, F, Y
21 Creatine N–CH3 3.03 s, N–CH2 3.94 s L, K, S, B, M, Ce, Co, I,F, P, W
22 Creatinine N–CH3 3.05 s, N–CH2 4.06 s K, Ce, Co, I, F, P
23 Cysteine bCH2 3.03 dd, aCH2 3.97 t S, Ce, Co, I, P
24 Dimethylamine CH3 2.72 s F
25 Ethanolamine CH2NH2 3.13 t, CH2COH 3.83 t B, I
26 Formate HCOOH 8.46 s L, K, S, B, Ce, Co, I, F, P, W
26 Fumarate HCOOH 6.51 s K, S, B, M, Ce, Co, I, P, Y
27 a-Galactose C6H 3.74 m, C2H 3.80 m, C3H 3.84 m, C4H 3.98 m, C5H
4.07 m, C1H 5.26 d
F, Y
28 b-Galactose C2H 3.48 m, C3H 3.63 m, C5H 3.69 m, C6H2 3.74 m, C4H
3.92 m, C1H 4.57 d
F, Y
29 a-Glucose C4H 3.42 m, C2H 3.54 m, CH3 3.72 m, 1/2C6H2 3.73 m,
1/2C6H2 3.77 m, C5H 3.87 m, C1H 5.23 d
L, K, S, M, F, P, Y, W
30 b-Glucose C2H 3.25 m, C4H 3.49 m, C5H 3.49 m, C3H 3.50 m,
1/2C6H2 3.88 m, 1/2C6H2 3.91 m, C1H 4.66 d
L, K, S, M, F, P, Y, W
31 Glutamate bCH2 2.02 m, cCH2 2.34 m, aCH 3.76 dd L, K, S, B, M, Ce, Co, I,F, P, Y, W
32 Glutamine bCH2 2.15 m, cCH2 2.44 m, aCH 3.77 t L, K, S, B, M, Ce, Co, I,F, P, Y
33 Glutarate CH2 1.78 m, 2HCOOH 2.17 t B
34 Glutathione CH2 2.17 m, CH2 2.53 m, S–CH2 2.95 dd, N–CH 3.83 m, CH
4.56 q
L
35 Glycerol 1/2CH2 3.58 m, 1/2CH2 3.62 m, CH 3.77 t L, K, S, B, M, Ce, P, W
36 Glycerophosphocholine N–(CH3)3 3.22 s, NCH2 3.68 m, OCH2 4.32 m L, K
37 Glycine aCH2 3.55 s L, K, S, B, M, Ce, Co, I,F, P, Y
38 Glycogen C2H 3.63 dd, C4H 3.66 dd, C5H 3.83 q, C6H 3.87 d, C3H 3.98
d, C1H 5.41 m
L
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Table 1 continued
Metabolite Assignement Matrix
39 Histidine 1/2CH2 3.16 dd, 1/2CH2 3.23 dd, CH 3.98 dd, CH 7.09 s, CH
7.90 s
L, K, S, B, Ce, Co, I, P, Y
40 Hypoxanthine CH 8.18 s, CH 8.21 s L, K, S, B, Ce, Co, I, P
41 Inosine 1/2CH2 3.83 dd, 1/2CH2 3.91 dd, C1H 4.27 dd, C2H 4.43 dd,
C3H 4.76 t, C4H 6.09 d, NH–CH 8.23 s, N–CH 8.34 s
M, Ce, Co, I
42 Isobutyrate (CH3)2 1.05 d, CH 2.38 m Ce
43 Isoleucine cCH3 0.94 t, dCH3 1.02 d, 1/2cCH2 1.26 m, 1/2cCH2 1.47 ddd,
bCH 2.01 m, aCH 3.65 d
L, K, S, B, M, Ce, Co, I,F, P, Y, W
44 Lactate bCH3 1.33 d, aCH 4.12 q L, K, S, B, Ce, Co, I, F, P, W
45 Leucine dCH3 0.93 d, bCH2 0.94 d, cCH 1.71 m, aCH 3.73 m L, K, S, B, Ce, Co, I, F, P, Y, W
46 Lipoproteins (HDL) CH3(CH2)n 0.84 t, (CH2)n 1.25 m, CH2–C=C 2.04 m, CH2–
C–O 2.24 m,=CH–CH2–CH=2.75 m, CH=CHCH2 5.32 m
L,B, F, P, Y
47 Lipoproteins (VLDL) CH3CH2CH2C=0.87 t, CH2CH2CH2CO 1.29 m, CH2CH2O
1.57 m, CH2–C=C 2.04 m, CH2–C–O 2.24 m,=CH–CH2–
CH=2.75 m, CH=CHCH2 5.32 m
L, B, F, P, Y
48 Lysine cCH2 1.46 m, dCH2 1.71 m, bCH2 1.84 m, eCH2 3.01 t L, K, S, B, I, F, Y
49 Malate 1/2HCOOH 2.38 dd, 1/2HCOOH 2.66 dd, H–CH 4.30 dd P
50 a-Mannose C5H 3.37 m, C4H 3.56 m, C3H 3.65 m, C6H 3.73 m, C2H
3.92 m, C1H 5.17 d
W
51 b-Mannose C4H 3.65 m, C5H 3.80 m, C3H 3.84, C6H 3.88, C2H 3.92 m,
C1H 4.89 d
W
52 Methionine dCH3 2.13 s, bCH 2.14 m, cCH2 2.60 t, aCH 3.78 t L, K, S, B, Ce, Co, I, F, P, Y
53 Methylamine CH3 3.29 s F
54 myo-Inositol C5H 3.29 t, C1H C3H 3.53 dd, C4H C5H 3.63 t, C2H 4.06 t L, K, S, B, Ce, Co, I, P, Y, W
55 N-Acetylglucosamine CH3 1.98 s, C3H 3.44&3.76 t, C5H 3.45&3.84 m, C4H
3.48&3.53 t, C2H 3.66&3.86 m, C6H 3.77 m & 3.87 dd,
C1H b 4.71 a 5.19 d, NH 8.10 d
F
56 N-acetyltyrosine CH3 1.92 s, 1/2bCH2 2.83 dd, 1/2bCH2 3.08 dd, aCH 4.37 m,
C3H C5H 6.84 m, C2H C4H 7.14 m, NH 7.75 d
F
57 Nicotinurate CH2 3.99 s, H5 7.60 dd, H4 8.25 d, H6 8.71 d, H2 8.94 s L, K, S, B, M, Ce, Co, I
58 O-Phosphocholine N-(CH3)3 3.21 s, CH2 3.58 m, O–CH2 4.16 m L, K, S, B, Ce, Co, I, Y
59 Ornithine 1/2cCH2 1.72 m, 1/2cCH2 1.82 m, bCH2 1.93 m, dCH2 3.04 t,
aCH 3.77 t
K, Y
60 Phenylalanine 1/2bCH2 3.12 dd, 1/2bCH2 3.26 dd, C3H C5H 7.33 m, C4H
7.35 m, C3H C6H 7.40 m
L, K, S, B, Ce, Co, I, F, P, Y, W
61 Proline cCH2 2.03 m, 1/2bCH2 2.03 m, 1/2bCH2 3.35 m, 1/2dCH2
3.38 m, 1/2dCH2 3.41 m, aCH 4.41 dd
L, K, S, B, Ce, Co, I, F, P, Y, W
62 Propionate CH3 1.04 t, CH2 2.17 q Ce, Co, F
63 Serine aCH 3.85 dd, 1/2bCH2 3.95 dd, 1/2bCH2 3.95 dd K, S, B, Ce, I, Y
64 scyllo-inositol CH 3.35 s K
65 Succinate CH2 2.04 s L, K, S, M, Ce, Co, I, F, P
66 Taurine N–CH2 3.26 t, S–CH2 3.43 t L, K, S, B, Ce, Co, I, P
67 Threonine cCH3 1.32 d, aCH 3.60 d, bCH 4.25 m L, K, S, B, Ce, I F, P, Y
68 Trigonelline CH3 4.43 s, C4H 8.07 m, C3H C5H 8.91 m, C1H 9.11 s F
69 Trimethylamine N-oxide N–(CH3)3 3.27 s L, K, B, Ce, Co, I, F, P
70 Tryptophan 1/2bCH2 3.31 dd, 1/2bCH2 3.49 dd, aCH 4.06 dd, C5H 7.21 t,
C6H 7.29 t, C1H 7.33 s, C3H 7.55 d, C4H 7.74 d
L, K, S, Ce, Co, I, F, Y
71 Tyrosine 1/2CH2 3.04 dd, 1/2CH2 3.18 dd, N–CH 3.94 dd, C3H C5H
6.89 m, C2H C6H 7.18 m
L, K, S, B, Ce, Co, I, F, P, Y, W
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4-aminobutyrate (GABA) (Fig. 2d). Carnosine was also
detected, which is a known brain antioxidant (Kohen et al.
1988). Surprisingly in contrast with muscle, it was not
possible to detect anserine, which has been reported to be
present in birds central nervous system(Biffo et al. 1990).
The metabolic profiles of gastrointestinal segments were
characterised by the presence of amino acids and short
chain fatty acids (SCFAs) (Fig. 3). A distinctive feature of
the ileum was the presence of glucose (Fig. 3c). Further-
more, the aromatic region was richer in phenylalanine and
tyrosine than colon and caecum. The ileum did not present
any unique metabolic feature. The metabolic profile of the
caecum contained high levels of short chain fatty acids and
amino acids (Fig. 3b). It was also possible to detect
isobutyrate a product of amino acid degradation by gut
bacteria. A very high level of O-phosphocholine, which has
been associated with an immunologic response to bacterial
infections (Wiens et al. 2003), was observed in this tissue.
The metabolic profile of the colon (Fig. 3a) was high in
short chain fatty acids (acetate, propionate and butyrate)
and amino acids (alanine, aspartate, glutamate, glutamine,
glycine, histidine, isoleucine, leucine, methionine, pheny-
lalanine, proline, tryptophan, tyrosine and valine). It was
the only tissue where we detected 3-hydroxyphenylacetate.
Unlike previously published results for rodents (Claus et al.
2008), glucose resonances were not visible in the colon,
despite its presence in faeces. Colon was the digestive
system related matrix presenting the poorest metabolic
diversity with thirty-six detectable metabolites. Finally, in
birds, faeces also contain urine since the digestive and
urinary systems share the same portal (the cloaca).
Therefore, it was not surprising to observe forty-three
metabolites, of which only ten of them pertained exclu-
sively to faeces: 2-hydroxybutyrate, 3-hydroxyisobutyrate,
arabinose, benzoate, dimethylamine, methylamine, N-
acteylglucosamine, N-acetyltyrosine and trigonelline
(Fig. 3d).
3.2 Matrix cross comparison
Cross tissues comparison of detectable metabolites was
performed using a Venn diagram (Fig. 4 and Supplemen-
tary material 3) and revealed the high metabolic variability
existing between the twelve biological matrices investi-
gated in this study. Only eight core metabolites were found
out of a total of seventy-eight detected molecules. Detected
core metabolites were all amino acids: alanine, glutamate,
isoleucine, leucine, phenylalanine, proline, tyrosine and
valine and can be considered ubiquitous stable metabolites.
Matrices related to general metabolic processes (liver,
kidney, spleen and plasma) shared twenty-eight metabo-
lites related to energy and protein metabolism. Biological
matrices related to the digestive system (colon, caecum,
ileum and faeces) shared 23 core metabolites associated
with microbial activity, energy metabolism and protein
degradation.
The largest source of metabolic variation between the
twelve biological matrices was visualised using PCA
(Fig. 5a). The scores of liver, kidney and spleen samples
were clustered together on the three first principal com-
ponents representing 77 % of the total variance (PC1, PC2
and PC3, Fig. 5a). Surprisingly, this was also observed for
muscle and brain cortex tissues. Metabolic profiles of
samples derived from the digestive system were also
grouped together but presented the highest variability
between samples of the same matrix. These were the
samples driving separation on the first component, which
was associated with increased levels in short chain fatty
Table 1 continued
Metabolite Assignement Matrix
72 UDP-glucose C4H 3.47 t, C2H 3.54 m, C3H 3.77 t, 1/2C6H 3.77 dd 1/2C6H
3.85 dd, C5H 3.88 m, 1/2CH2 4.19 m, 1/2CH2 4.24 m, O–
CH 4.28 m, C’3H 4.36 dd, C’2H 4.37 dd, C1H 5.97 d, O–
CH–N 5.97 d, N–CH 7.94 d
W
73 UDP-N-acetyl glucose CH3 2.07 s, C4H 3.55 t, C3H 3.80 t, 1/2C6H 3.81 dd, 1/2C6H
3.86 dd, C5H 3.91 m, C2H 3.98 m, 1/2CH2 4.18 m, 1/2CH2
4.23 m, O–CH 4.28 m, C’3H 4.35 dd, C’2H 4.36 dd, C1H
5.51 dd, CH 5.95 d, O–CH–N 5.97 d, N–CH 7.94 d, NH 8.35
d
W
74 Uracil C5H 5.80 d, C6H 7.54 d L, K, S, B, Ce, Co, P
75 Uridine 1/2CH2 3.81 dd, 1/2CH2 3.92 dd, C4H 4.12 dt, C3H 4.24 dd,
C2H 4.36 dd, C1H 5.88 d, C5H 5.92 m, C6H 7.88 d
W, S
76 Valerate CH3 0.88 t, cCH2 1.29 m, bCH2 1.51 m, aCH2 2.17 t Ce, F
77 Valine cCH3 0.98 d, c’CH3 1.04 d, bCH 2.27 m, aCH 3.62 d L, K, S, B, Ce, Co, I, F, P, Y, W
78 Xanthine CH 7.92 s K, S, B, Ce, Co, I
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acids produced by gut microbial activity. Finally, plasma,
egg yolk and egg white were clustered together on PC2 due
to their high glucose content. Yolk and plasma metabolic
profiles also clustered together because they shared high
lipid levels. Interestingly, egg-derived samples were the
most metabolically homogenous, with the least inter-indi-
vidual variability indicating that their metabolism is tightly
regulated.
The metabolic profiles of colon, caecum, ileum and
faecal water shared many similar metabolic patterns. 23
shared metabolites were related to microbial catabolism of
polysaccharides (acetate, butyrate) and protein degradation
(amino acids). Propionate, another important product of
polysaccharide fermentation was not found in the ileum
but was observed in all other digestive matrices, indicating
that propionate fermentation does not occur in this part of
the digestive system. It was not possible to separate cae-
cum and colon metabolic profiles using pairwise compar-
ison such as orthogonal projection to latent structure
discriminant analysis (O-PLS DA) due to their
high metabolic similarity. However, it was possible to
distinguish the ileum from colon and caecum based
on lower SCFAs concentration, which suggests that gut
microbiota (GM) at this level of the gastro intestinal (GI)
tract is less active (Fig. 5b). The same was observed in
mice where more SCFAs were found in the lower part of
the GI tract due to high microbial colonization (Martin
et al. 2009a, b). This metabolic characteristic clearly sep-
arated the cluster of GI samples from the other matrices on
the PCA plot. Faecal water was the biofluid presenting the
highest quantity of identifiable metabolites, of which ten
were uniquely found in this matrix probably as a result of
the complexity of the food provided (see Supplementary
material 4 and Fig. 5a and b) and high microbial activity.
These ten metabolites were mostly SCFAs, likely derived
from gut microbiota activity as well as methyl donors
including methylamines. The high similarity level existing
between GI tract metabolic profiles and faecal waters
indicates a great level of exchange between the GI lumen
and the enterocytes. Birds were fed with un-medicated
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Fig. 5 Metabolic variability between the twelve described chicken
matrices. a 3-Dimentional PCA score plot derived from the 1H-NMR
spectra of liver, kidney, spleen, brain, muscle, plasma, white, yolk,
colon, caecum, ileum and faeces of six animals. b PCA loadings
representing the metabolic variations on PC1. c PCA loadings
representing the metabolic variations on PC2. d PCA loadings
representing the metabolic variations on PC3
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layer pellets (Dodson and Horrell) that mainly contain
wheat rich in complex carbohydrate, vegetable oil and soya
as a protein source (for more information see Supplemen-
tary material 4).
Highly metabolically active tissues, liver, kidney and
spleen, appear to be very similar although they serve dif-
ferent purposes (i.e. spleen is more involved in immune
control) as presented on the PCA plot. However, due to the
high number of studied matrices and their high variability,
this model lacks of sensitivity to separate the three tissues
which present a high level of metabolic similarity, both
qualitatively and quantitatively. Nevertheless, they also
present distinct features such as glucose and creatine levels
that were detectable using pairwise comparisons and PCA
(Supplementary material 4).
Egg metabolic profiles were dominated by energy
metabolites (saccharides) and amino acids for both yolk
and white matrices. Yolk was also extremely rich in
cholesterol and lipids, which are essential to cell membrane
formation and are also sources of energy (Yeagle 1989;
Spector and Yorek 1985). These results confirm the high
nutritive value of chicken eggs due to their initial purpose
to support fetal development.
The metabolic profile of muscle has only been described
in mice for cardiac muscle (Griffin et al. 2001), which in its
structure and function is different to striated skeletal
muscle. Despite their differences, both muscle metabolic
profiles appear to be characterized by lactate, which is the
main product of glucose anaerobic fermentation by muscle
during exercise (Brooks 1986). Creatine was also found in
high concentration, which is consistent with its important
role as a phosphate donor to quickly regenerate ATP dur-
ing muscular contraction (Bessman and Geiger 1981;
Casey et al. 1990). Finally taurine, also involved in con-
tractility, was highly concentrated (Pierno et al. 1998).
In comparison to previously described metabolic pro-
files of mammals from mice, pigs and humans, these pro-
files show high qualitative but not necessarily quantitative
similarities for liver, kidney, ileum, colon and plasma. This
shows that despite the level of genetic and evolutionary
differences existing between birds and mammals, their core
metabolic functions remain very similar. The main differ-
ence previously mentioned between chicken and mam-
malian metabolic profiles were observed in the liver where
we observed that glutathione levels were noticeably lower
in birds. Glutathione is involved in cell protection due to its
antioxidant properties (Meister 1983). This difference had
been already reported in quail (Gregus et al. 1983), sug-
gesting a major shift in hepatic detoxification mechanisms
between mammals and birds. Indeed, several publications
have reported a higher susceptibility of birds to toxic
substances and a higher bioaccumulation in comparison to
mammals (Walker 1983) consistent with a modification of
detoxification metabolism during evolution.
4 Conclusion
This study presents a large overview of chicken metabolic
profiles in various tissues and biofluids that could be used
as a database for future NMR-based metabonomic analyses
in avian studies. Future works focussing on the metabolic
impact of GI infection and treatment on host metabolism
and on the influence of diet and growth condition would be
useful to assess product quality (i.e. meat and egg). These
metabolic data integrated with other ‘omics’ approaches
will contribute to the understanding of host response to
environmental changes, infection and treatment that should
lead to improved animal welfare.
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